Stability of Blood Coagulation Factors and Inhibitors in Blood Drawn into Half-Strength Citrate Anticoagulant
- 1 August 1996
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 71 (2) , 97-102
- https://doi.org/10.1046/j.1423-0410.1996.7120097.x
Abstract
Drawing of blood into a citrate‐phosphate‐dextrose (CPD) solution with a reduced citrate concentration has been shown to improve the maintenance of coagulation factor VIII (F VIII) in plasma and to give possibilities to improve erythrocyte preservation. We studied the quality of plasma obtained from whole blood drawn under continuous mixing into CPD in which the citrate concentration was reduced by 50% (0.5CPD). The blood was stored at room temperature for 8 h before component preparation. We confirmed improved stability of F VIII by 0.5CPD. We found no clinically significant changes in inhibitors to the coagulation and kallikrein systems, and no signs of activation of these systems, during the 8‐hour holding time. In control blood drawn into CPD, F VIII and coagulation factor IX decreased by 0.09 IU/ml (8%) and 0.07 U/ml (7%), respectively, otherwise we found no significant differences between 0.5CPD plasma and CPD plasma.Keywords
This publication has 21 references indexed in Scilit:
- Half-strength citrate CPD and new additive solutions for improved blood preservation. 2. The effect of storage at ambient temperature before component preparation and different means of supplying glucose to the red cellsTransfusion Medicine, 1993
- Half-strength citrate CPD and new additive solutions for improved blood preservation. I. Studies of six experimental solutionsTransfusion Medicine, 1993
- Storage of Whole Blood for up to 24 Hours at Ambient Temperature prior to Component PreparationVox Sanguinis, 1989
- Effect of delayed blood processing on the yield of factor VIII in cryoprecipitate and factor VIII concentrateTransfusion, 1988
- Studies on the Procurement of Blood Coagulation Factor VIIIVox Sanguinis, 1988
- Studies on the Procurement of Blood Coagulation Factor VIII in vitro Studies on Blood Components Prepared in Half‐Strength Citrate AnticoagulantVox Sanguinis, 1987
- Activation of Blood Coagulation, Fibrinolytic and Kallikrein Systems during Storage of PlasmaVox Sanguinis, 1984
- FPA Content - a Criterion of Quality for Plasma as Factor VIII SourceVox Sanguinis, 1983
- Measurement of Fibrinopeptide A in Human BloodJournal of Clinical Investigation, 1974
- Purification and Stabilization of Factor VNature, 1963